|
Figure 2.
(a) Superposition of the motavizumab-bound peptide (gray) and
residues 229–252 of the PIV5 F glycoprotein structure (red).
(b) Ribbon representation of the model of motavizumab Fab (green
and blue) bound to the PIV5 F glycoprotein monomer (tan) via the
superposition shown in a. (c) Same as b, except the entire PIV5
F glycoprotein trimer is shown (tan, green, pink). (d)
Magnification of the boxed area shown in c. (e) Gel filtration
elution profile and corresponding Coomassie blue–stained
SDS-PAGE gel of the RSV F[0] Fd glycoprotein. (f) Gel filtration
elution profile and corresponding Coomassie blue–stained
SDS-PAGE gel of a mixture of RSV F[0] Fd glycoprotein and excess
palivizumab Fab. Densitometric analysis of the gel yields a
ratio of 2.97 Fabs per trimer.
|